- Filed
- May 14, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 13, 2026 | 161.49K sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 16.29M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 18.31M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $14.32M |
| Capex | Q1 2026 · Mar 31, 2026 | $82K |
| Capex | Q1 2026 · Mar 31, 2025 | $3.05M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $12.66M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $7.04M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $46.21M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $60.27M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $297.72M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $314.45M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $331.41M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $326.26M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $967.29M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $940.96M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $1.27B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $1.26B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.01 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.04 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.01 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.04 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $1.4M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $1.34M |
| Net Income | Q1 2026 · Mar 31, 2026 | $119K |
| Net Income | Q1 2026 · Mar 31, 2025 | $705K |
| Net Income restated | Q1 2026 · Mar 31, 2024 | −$119K |